626 related articles for article (PubMed ID: 24406159)
1. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
3. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance].
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
9. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
[TBL] [Abstract][Full Text] [Related]
10. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy predicts lymph node metastasis in early gastric cancer: a retrospective analysis.
Dong LF; Wang LB; Shen JG; Xu CY
Dig Surg; 2012; 29(2):124-9. PubMed ID: 22538386
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
17. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of SPARC gene expression in patients with gastric cancer.
Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
20. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
